Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCMV5322A/MCMV3068A (RG7667) for CMV Prevention in Kidney Transplant
NCT01753167Phase 2Completed
- Sponsor
- Genentech
- Start
- Dec 2012
- Primary completion
- Oct 2014
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of MCMV5322A, MCMV3068A in cytomegalovirus infection (CMV), sponsored by Genentech. Started Dec 2012; status: completed.
02
Drugs
MCMV5322AMCMV3068A
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01753167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753167.